Published on in Vol 14 (2025)

This is a member publication of University College London (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68113, first published .
Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Sustained Virological Response as a Surrogate Marker for Mortality, Decompensated Cirrhosis, or Hepatocellular Carcinoma in People With Chronic Hepatitis C Virus Infection Treated With Direct-Acting Antivirals: Protocol for a Bayesian and Causal Mediation Analysis

Kurinchi Selvan Gurusamy   1, 2 , PhD ;   Christian Gluud   2, 3, 4 , MD, Dr Med Sci

1 Division of Surgery and Interventional Science, University College London, London, United Kingdom

2 Cochrane Hepato-Biliary Group, Copenhagen, Denmark

3 The Copenhagen Trial Unit, Copenhagen, Denmark

4 Department of Regional Health Research, Odense, Denmark

Corresponding Author:

  • Kurinchi Selvan Gurusamy, PhD
  • Division of Surgery and Interventional Science
  • University College London
  • 9th Floor, Royal Free Hospital, Royal Free Campus (Hampstead Campus)
  • Rowland Hill Street
  • London NW3 2PF
  • United Kingdom
  • Phone: 44 02080168116
  • Email: k.gurusamy@ucl.ac.uk